Christopher Mutz
HEAD OF RARE DISEASE at ANI Pharmaceuticals. Based in Baudette, Minnesota.
- Rank
- 12345th of 14,644
- Companies held
- 1
- Largest holding
- ANIP, 100.0% of total
- Latest SEC filing
- Mar 13, 2026
What the $6.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ANI Pharmaceuticals ANIP Common Stock | Directly | 91,309 | $69.03 | $6.3M | 100.0% | Form 4, Mar 13, 2026 |
Share counts are the amounts Christopher Mutz reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12342 | Andreas Fibig CEO, International Flavors & Fragrances. New York, NY | $6.3M |
| 12343 | Damien McDevitt See Remarks, Aspen Neuroscience. San Diego, CA | $6.3M |
| 12344 | Jason L. Vollmer CFO, MDU Resources Group. Bismarck, ND | $6.3M |
| 12345 | Christopher Mutz HEAD OF RARE DISEASE, ANI Pharmaceuticals. Baudette, MN | $6.3M |
| 12346 | Matthew Pauls CHIEF EXECUTIVE OFFICER, Savara. Durham, NC | $6.3M |
| 12347 | J. Matthew Mackowski Director, Alpha Teknova. San Francisco, CA | $6.3M |
| 12348 | Vishal Agrawal Chief Strat & Corp Dev Officer, Humana. Louisville, KY | $6.3M |
Other ANI Pharmaceuticals insiders
All ANIP insiders- Muthusamy Shanmugam$37.1MHEAD OF R&D, COO-NOVITIUM OPS. #3181 overall
- Nikhil Lalwani$22.7MPRESIDENT & CEO. #4723 overall
- Chad Gassert$16.1MSVP - CORP. DEV. & STRATEGY. #6089 overall
- Stephen P. Carey$11.5MSVP & CFO. #7928 overall
- James G. Marken$8.1MSVP OPS & PROD DEV. #10274 overall
- Ori Gutwerg$5.2MSVP, GENERICS. #14053 overall
Questions
How much stock does Christopher Mutz own?
Christopher Mutz holds $6,303,060 in listed stock based on SEC filings and current prices, mostly ANI Pharmaceuticals (ANIP). That ranks 12345th on the Stock Rich List.
Is this Christopher Mutz's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Christopher Mutz last buy or sell stock?
The most recent open-market trade on file is a sale of 3,162 ANIP shares on Mar 13, 2026 at $71.64.